vs
Side-by-side financial comparison of CAPITAL CITY BANK GROUP INC (CCBG) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $63.5M, roughly 1.3× CAPITAL CITY BANK GROUP INC). CAPITAL CITY BANK GROUP INC runs the higher net margin — 21.6% vs -38.1%, a 59.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 6.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 6.0%).
Texas Capital Bank is a bank headquartered in Dallas, Texas. The bank has branches located in every major city in Texas. Its parent bank holding company is Texas Capital Bancshares. It also operates an online-only banking division, Bask Bank.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
CCBG vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $63.5M | $83.1M |
| Net Profit | $13.7M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 29.3% | -4.1% |
| Net Margin | 21.6% | -38.1% |
| Revenue YoY | 6.0% | 20.2% |
| Net Profit YoY | 4.7% | -27.9% |
| EPS (diluted) | $0.80 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $63.5M | $76.4M | ||
| Q3 25 | $65.9M | $83.3M | ||
| Q2 25 | $63.2M | $79.2M | ||
| Q1 25 | $61.5M | $69.2M | ||
| Q4 24 | $59.9M | $68.2M | ||
| Q3 24 | $59.7M | $58.4M | ||
| Q2 24 | $58.9M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $13.7M | $-29.8M | ||
| Q3 25 | $15.9M | $-21.4M | ||
| Q2 25 | $15.0M | $-19.6M | ||
| Q1 25 | $16.9M | $-24.7M | ||
| Q4 24 | $13.1M | $-18.9M | ||
| Q3 24 | $13.1M | $-21.0M | ||
| Q2 24 | $14.2M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 29.3% | -40.6% | ||
| Q3 25 | 32.0% | -27.8% | ||
| Q2 25 | 31.7% | -28.0% | ||
| Q1 25 | 35.8% | -39.7% | ||
| Q4 24 | 29.0% | -28.9% | ||
| Q3 24 | 26.1% | -38.4% | ||
| Q2 24 | 29.3% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 21.6% | -39.1% | ||
| Q3 25 | 24.2% | -25.7% | ||
| Q2 25 | 23.8% | -24.7% | ||
| Q1 25 | 27.4% | -35.8% | ||
| Q4 24 | 21.9% | -27.6% | ||
| Q3 24 | 22.0% | -35.9% | ||
| Q2 24 | 24.0% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.80 | $-0.54 | ||
| Q3 25 | $0.93 | $-0.38 | ||
| Q2 25 | $0.88 | $-0.35 | ||
| Q1 25 | $0.99 | $-0.45 | ||
| Q4 24 | $0.78 | $-0.34 | ||
| Q3 24 | $0.77 | $-0.40 | ||
| Q2 24 | $0.83 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $552.9M | $347.7M |
| Total Assets | $4.4B | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $552.9M | $365.9M | ||
| Q3 25 | $540.6M | $380.3M | ||
| Q2 25 | $526.4M | $385.8M | ||
| Q1 25 | $512.6M | $389.2M | ||
| Q4 24 | $495.3M | $402.2M | ||
| Q3 24 | $476.5M | $241.2M | ||
| Q2 24 | $461.0M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $4.4B | $508.1M | ||
| Q3 25 | $4.3B | $511.5M | ||
| Q2 25 | $4.4B | $513.1M | ||
| Q1 25 | $4.5B | $519.4M | ||
| Q4 24 | $4.3B | $534.0M | ||
| Q3 24 | $4.2B | $374.1M | ||
| Q2 24 | $4.2B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $87.6M | — |
| Free Cash FlowOCF − Capex | $80.0M | — |
| FCF MarginFCF / Revenue | 126.1% | — |
| Capex IntensityCapex / Revenue | 12.0% | — |
| Cash ConversionOCF / Net Profit | 6.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | $150.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $87.6M | $-10.3M | ||
| Q3 25 | $21.6M | $-6.6M | ||
| Q2 25 | $32.6M | $-15.0M | ||
| Q1 25 | $21.9M | $-17.0M | ||
| Q4 24 | $63.6M | $-32.4M | ||
| Q3 24 | $12.8M | $-18.8M | ||
| Q2 24 | $24.9M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $80.0M | $-12.2M | ||
| Q3 25 | $19.8M | $-9.5M | ||
| Q2 25 | $30.8M | $-17.8M | ||
| Q1 25 | $19.5M | $-18.8M | ||
| Q4 24 | $54.9M | $-33.6M | ||
| Q3 24 | $10.5M | $-19.0M | ||
| Q2 24 | $23.0M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 126.1% | -15.9% | ||
| Q3 25 | 30.1% | -11.4% | ||
| Q2 25 | 48.7% | -22.5% | ||
| Q1 25 | 31.7% | -27.2% | ||
| Q4 24 | 91.7% | -49.2% | ||
| Q3 24 | 17.6% | -32.6% | ||
| Q2 24 | 39.0% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 12.0% | 2.4% | ||
| Q3 25 | 2.6% | 3.4% | ||
| Q2 25 | 2.9% | 3.5% | ||
| Q1 25 | 3.9% | 2.7% | ||
| Q4 24 | 14.5% | 1.7% | ||
| Q3 24 | 3.8% | 0.4% | ||
| Q2 24 | 3.3% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 6.39× | — | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | 2.17× | — | ||
| Q1 25 | 1.30× | — | ||
| Q4 24 | 4.86× | — | ||
| Q3 24 | 0.97× | — | ||
| Q2 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCBG
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |